BlackRock Amends Pfizer Stake: Ownership Update Filed

Ticker: PFE · Form: SC 13G/A · Filed: 2024-01-26T00:00:00.000Z

Sentiment: neutral

Topics: institutional-ownership, amendment, passive-investing

TL;DR

**BlackRock just updated its Pfizer holdings, watch for market reaction!**

AI Summary

BlackRock Inc. filed an amended SC 13G/A on January 26, 2024, indicating a change in its ownership stake in Pfizer Inc. as of December 31, 2023. This amendment, number 14, updates BlackRock's previously reported holdings of Pfizer's Common Stock. This matters to investors because BlackRock is a major institutional investor, and changes in its holdings can signal shifts in its confidence in Pfizer's future performance, potentially influencing other investors' decisions.

Why It Matters

This filing shows BlackRock's updated position in Pfizer, which can influence market sentiment and provide insight into a major institutional investor's view of the company.

Risk Assessment

Risk Level: low — This filing is a routine update from a large institutional investor and does not inherently signal high risk for Pfizer.

Analyst Insight

An investor should note BlackRock's continued interest in Pfizer, but this filing alone doesn't provide enough detail to make a significant investment decision. Further analysis of BlackRock's specific share count changes (which are not detailed in this excerpt) would be necessary.

Key Numbers

Key Players & Entities

Forward-Looking Statements

FAQ

What type of filing is this document?

This document is an SC 13G/A, which is an amendment to a Schedule 13G, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 14)' sections.

Who is the reporting person in this filing?

The reporting person is BlackRock Inc., as indicated under '(1)Names of reporting persons. BlackRock,' and in the 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc.' section.

What company's securities are the subject of this filing?

The subject company is PFIZER INC, as stated under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC' and '(Name of Issuer) PFIZER INC'.

What was the date of the event that required this filing?

The date of the event which required this filing was December 31, 2023, as specified under '(Date of Event Which Requires Filing of this Statement) December 31, 2023'.

What is the CUSIP number for the class of securities reported?

The CUSIP number for the Common Stock of Pfizer Inc. is 717081103, as listed under '(CUSIP Number) 717081103' and 'CUSIP No. 717081103'.

From the Filing

0001086364-24-004377.txt : 20240126 0001086364-24-004377.hdr.sgml : 20240126 20240126114944 ACCESSION NUMBER: 0001086364-24-004377 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240126 DATE AS OF CHANGE: 20240126 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-60005 FILM NUMBER: 24565878 BUSINESS ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 BUSINESS PHONE: 2127332323 MAIL ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc. CENTRAL INDEX KEY: 0001364742 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] ORGANIZATION NAME: 02 Finance IRS NUMBER: 320174431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-810-5300 MAIL ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: BlackRock, Inc. DATE OF NAME CHANGE: 20060929 FORMER COMPANY: FORMER CONFORMED NAME: New BlackRock, Inc. DATE OF NAME CHANGE: 20060601 SC 13G/A 1 us7170811035_012624.txt us7170811035_012624.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 14) PFIZER INC -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 717081103 -------------------------------------------------------- (CUSIP Number) December 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 717081103 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 392763728 (6) Shared voting power 0 (7) Sole dispositive power 434748255 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 434748255 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 7.7% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- PFIZER INC Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 Item 2. 2(a) Name of person filing: ---------------------------------------------------------------------- BlackRock, Inc. 2(b) Addre

View on Read The Filing